Algernon Pharmaceuticals inks deal with Charles River Laboratories for preclinical work on DMT for stroke
Algernon Pharmaceuticals Inc (CSE:AGN) (OTCQB:AGNPF) (FRA:AGW), the drug repurposing company, said pre-clinical studies on the psychedelic compound DMT to treat stroke will be carried out at the Charles River research facility in Finland.
The company has inked a deal with lab services firm Charles River Laboratories for research studies of AP-188, or DMT, it told investors.
READ: Algernon Pharmaceuticals poised to investigate psychedelic compound DMT as treatment for stroke
As reported earlier this month, Algernon said that, unlike other companies researching psychedelic drugs, it will be focusing on a sub-hallucinogenic, or microdose of DMT given via continuous intravenous administration - the aim being the patient will not have a psychedelic experience.
This approach may also allow for a quicker pathway to regulatory approval, including a Breakthrough Therapy designation from the US FDA, it had noted.
Algernon plans to be the first company globally to pursue DMT for stroke in humans and is planning to begin a clinical trial as soon as possible this year.
“The company is very pleased to have retained Charles River Labs, a trusted vendor that we have worked with before on other research projects,” said Christopher J. Moreau, CEO of Algernon Pharmaceuticals.
“They have all of the necessary permits and licenses to handle DMT, which will allow us to move quickly with our research program. They are a recognized world leader for pre-clinical neurological studies.”
DMT (N,N-Dimethyltryptamine), occurs naturally in many plants and animals and is a hallucinogenic tryptamine drug producing effects similar to those of other psychedelics like LSD, ketamine, psilocybin and psilocin.
It has been shown to induce neuroplasticity in a number of key preclinical studies and is believed to activate pathways involved with forming neuron connections.
Millions of people suffer the debilitating consequences of a stroke each year. In 2018, the global stroke treatment market was valued at around US$8 billion. This is expected to reach a value of around US$15 billion by the year 2027, with a compound annual growth rate of around 7%.
Contact the author at [email protected]
Story by ProactiveInvestors
Source: http://www.proactiveinvestors.com/companies/news/940673/algernon-pharmaceuticals-inks-deal-with-charles-river-laboratories-for-preclinical-work-on-dmt-for-stroke-940673.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.
| Visits: | 1,706,517,730 |
| Stories: | 8,445,879 |
Whistler Blowers, Insiders
